This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Express Scripts, others ask US appeals court to reverse order on injunction against FTC case

( April 16, 2025, 22:31 GMT | Official Statement) -- MLex Summary: Express Scripts and other pharmacy benefit managers asked a US appeals court to reverse an order denying an injunction against an administrative proceeding initiated by the Federal Trade Commission. “This case instead challenges the constitutionality of the commission’s proceeding, and of its choice to bring its claims against plaintiffs in its own in-house tribunal rather than in an Article III court,” they said. See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections